Today's Analyst Stock Ratings | Upgrades, Downgrades

SPY766.47−0.00%QQQ715.45−0.41%BTC/USD—DIA520.10+0.23%GLD377.64−0.54%TLT79.74+0.35%

							Get Alert
Oct 8, 2026	XPOXPO	$185.35	24.09%	J. Bruce ChanStifel 61%	230 257	Previous Buy Current Buy	Get Alert
Oct 7, 2026	XPOXPO	$185.35	18.69%	Lucas ServeraTruist Securities 72%	220 240	Previous Buy Current Buy	Get Alert
Oct 7, 2026	XPOXPO	$185.35	20.85%	Ariel RosaCitigroup 77%	220 224	Previous Neutral Current Buy	Get Alert
Oct 5, 2026	XPOXPO	$185.35	10.6%	Brian OssenbeckJP Morgan 69%	205 214	Previous Overweight Current Overweight	Get Alert
Oct 2, 2026	XPOXPO	$185.35	4.67%	Bascome MajorsSusquehanna 63%	194 225	Previous Neutral Current Neutral	Get Alert
Oct 2, 2026	XPOXPO	$185.35	24.09%	Ken HoexterB of A Securities 66%	228 230	Previous Buy Current Buy	Get Alert
Sep 10, 2026	XPOXPO	$185.35	31.64%	David VernonBernstein 57%	244	Previous Initiates Current Outperform	Get Alert
Sep 8, 2026	XPOXPO	$185.35	18.69%	Ariel RosaCitigroup 77%	220 221	Previous Neutral Current Neutral	Get Alert
Sep 4, 2026	XPOXPO	$185.35	23.01%	Ken HoexterB of A Securities 66%	228 248	Previous Buy Current Buy	Get Alert
Jul 31, 2026	XPOXPO	$185.35	19.23%	Ariel RosaCitigroup 77%	221 226	Previous Neutral Current Neutral	Get Alert
Jul 31, 2026	XPOXPO	$185.35	23.01%	Jason H. SeidlTD Cowen 35%	224 228	Previous Buy Current Buy	Get Alert
Jul 31, 2026	XPOXPO	$185.35	28.41%	Scott SchneebergerOppenheimer 60%	236 238	Previous Outperform Current Outperform	Get Alert
Jul 31, 2026	XPOXPO	$185.35	45.67%	Aaron HechtStephens & Co. 56%	255 270	Previous Overweight Current Overweight	Get Alert
Jul 21, 2026	XPOXPO	$185.35	30.02%	J. Bruce ChanStifel 61%	237 241	Previous Buy Current Buy	Get Alert
Jul 15, 2026	XPOXPO	$185.35	—	Jeff KauffmanCitizens 35%	—	Previous Initiates Current Market Perform	Get Alert
Jul 14, 2026	XPOXPO	$185.35	15.46%	Bascome MajorsSusquehanna 63%	212 214	Previous Neutral Current Neutral	Get Alert
Jul 13, 2026	XPOXPO	$185.35	21.39%	Patrick BrownRaymond James 81%	225 233	Previous Outperform Current Outperform	Get Alert
Jul 9, 2026	XPOXPO	$185.35	21.93%	Ariel RosaCitigroup 77%	226 236	Previous Neutral Current Neutral	Get Alert
Jul 7, 2026	XPOXPO	$185.35	38.66%	Thomas WadewitzUBS 75%	236 257	Previous Buy Current Buy	Get Alert
Jul 6, 2026	XPOXPO	$185.35	-37.96%	Ravi ShankerMorgan Stanley 58%	105 115	Previous Underweight Current Underweight	Get Alert
Jul 1, 2026	XPOXPO	$185.35	25.17%	Jonathan ChappellEvercore ISI Group 72%	222 232	Previous In-Line Current Outperform	Get Alert
Jun 15, 2026	XPOXPO	$185.35	27.33%	Ariel RosaCitigroup 77%	221 236	Previous Neutral Current Neutral	Get Alert
Jun 8, 2026	XPOXPO	$185.35	13.3%	Brian OssenbeckJP Morgan 69%	208 210	Previous Overweight Current Overweight	Get Alert
Jun 5, 2026	XPOXPO	$185.35	34.88%	Christian WetherbeeWells Fargo 71%	235 250	Previous Overweight Current Overweight	Get Alert
Jun 4, 2026	XPOXPO	$185.35	32.18%	Fadi ChamounBMO Capital 77%	240 245	Previous Outperform Current Outperform	Get Alert
Jun 4, 2026	XPOXPO	$185.35	32.72%	Ken HoexterB of A Securities 66%	244 246	Previous Buy Current Buy	Get Alert
Jun 2, 2026	XPOXPO	$185.35	14.38%	Bascome MajorsSusquehanna 63%	210 212	Previous Neutral Current Neutral	Get Alert
May 4, 2026	XPOXPO	$185.35	27.33%	Scott SchneebergerOppenheimer 60%	228 236	Previous Outperform Current Outperform	Get Alert
May 1, 2026	XPOXPO	$185.35	20.85%	Jason H. SeidlTD Cowen 35%	192 224	Previous Buy Current Buy	Get Alert
May 1, 2026	XPOXPO	$185.35	19.23%	Ariel RosaCitigroup 77%	207 221	Previous Neutral Current Neutral	Get Alert
May 1, 2026	XPOXPO	$185.35	34.88%	Brandon OglenskiBarclays 64%	195 250	Previous Overweight Current Overweight	Get Alert
May 1, 2026	XPOXPO	$185.35	19.77%	Jonathan ChappellEvercore ISI Group 72%	198 222	Previous In-Line Current In-Line	Get Alert
May 1, 2026	XPOXPO	$185.35	26.79%	Christian WetherbeeWells Fargo 71%	225 235	Previous Overweight Current Overweight	Get Alert
May 1, 2026	XPOXPO	$185.35	29.48%	Christopher KuhnBenchmark 64%	220 240	Previous Buy Current Buy	Get Alert
Apr 22, 2026	XPOXPO	$185.35	48.37%	Stephanie MooreJefferies 70%	250 275	Previous Buy Current Buy	Get Alert
Apr 16, 2026	XPOXPO	$185.35	25.17%	J. Bruce ChanStifel 61%	206 232	Previous Buy Current Buy	Get Alert
Apr 7, 2026	XPOXPO	$185.35	11.68%	Ariel RosaCitigroup 77%	205 207	Previous Neutral Current Neutral	Get Alert
Apr 7, 2026	XPOXPO	$185.35	21.39%	Christian WetherbeeWells Fargo 71%	205 225	Previous Overweight Current Overweight	Get Alert
Mar 27, 2026	XPOXPO	$185.35	6.82%	Jonathan ChappellEvercore ISI Group 72%	198 200	Previous In-Line Current In-Line	Get Alert
Mar 10, 2026	XPOXPO	$185.35	8.44%	Brian OssenbeckJP Morgan 69%	189 201	Previous Overweight Current Overweight	Get Alert
Mar 3, 2026	XPOXPO	$185.35	23.01%	Scott SchneebergerOppenheimer 60%	198 228	Previous Outperform Current Outperform	Get Alert
Feb 11, 2026	XPOXPO	$185.35	13.3%	Bascome MajorsSusquehanna 63%	160 210	Previous Positive Current Neutral	Get Alert
Feb 9, 2026	XPOXPO	$185.35	10.6%	Ariel RosaCitigroup 77%	167 205	Previous Neutral Current Neutral	Get Alert
Feb 6, 2026	XPOXPO	$185.35	1.97%	Brian OssenbeckJP Morgan 69%	160 189	Previous Overweight Current Overweight	Get Alert
Feb 6, 2026	XPOXPO	$185.35	6.82%	Scott SchneebergerOppenheimer 60%	154 198	Previous Outperform Current Outperform	Get Alert
Feb 6, 2026	XPOXPO	$185.35	11.14%	J. Bruce ChanStifel 61%	166 206	Previous Buy Current Buy	Get Alert
Feb 6, 2026	XPOXPO	$185.35	7.9%	Lucas ServeraTruist Securities 72%	160 200	Previous Buy Current Buy	Get Alert
Feb 6, 2026	XPOXPO	$185.35	10.6%	Christian WetherbeeWells Fargo 71%	147 205	Previous Overweight Current Overweight	Get Alert
Jan 21, 2026	XPOXPO	$185.35	-10.44%	J. Bruce ChanStifel 61%	166 167	Previous Buy Current Buy	Get Alert
Jan 16, 2026	XPOXPO	$185.35	-10.98%	Christopher KuhnBenchmark 64%	150 165	Previous Buy Current Buy	Get Alert
Jan 13, 2026	XPOXPO	$185.35	-20.15%	Jonathan ChappellEvercore ISI Group 72%	148 151	Previous Outperform Current In-Line	Get Alert
Jan 12, 2026	XPOXPO	$185.35	-13.68%	Brian OssenbeckJP Morgan 69%	160 163	Previous Overweight Current Overweight	Get Alert
Jan 9, 2026	XPOXPO	$185.35	-14.76%	Jason SeidlTD Cowen 56%	141 158	Previous Buy Current Buy	Get Alert
Jan 8, 2026	XPOXPO	$185.35	—	Scott GroupWolfe Research 61%	—	Previous Outperform Current Peer Perform	Get Alert
Jan 8, 2026	XPOXPO	$185.35	-7.74%	Ariel RosaCitigroup 77%	164 171	Previous Buy Current Neutral	Get Alert
Jan 5, 2026	XPOXPO	$185.35	-13.68%	Bascome MajorsSusquehanna 63%	160 162	Previous Positive Current Positive	Get Alert
Dec 16, 2025	XPOXPO	$185.35	-9.9%	J. Bruce ChanStifel 61%	149 167	Previous Buy Current Buy	Get Alert
Dec 8, 2025	XPOXPO	$185.35	-51.44%	Ravi ShankerMorgan Stanley 58%	83 90	Previous Underweight Current Underweight	Get Alert
Dec 8, 2025	XPOXPO	$185.35	-12.06%	Brian OssenbeckJP Morgan 69%	163 166	Previous Overweight Current Overweight	Get Alert
Dec 3, 2025	XPOXPO	$185.35	-11.52%	Ariel RosaCitigroup 77%	159 164	Previous Buy Current Buy	Get Alert
Dec 2, 2025	XPOXPO	$185.35	-14.76%	Ken HoexterB of A Securities 66%	151 158	Previous Buy Current Buy	Get Alert
Nov 17, 2025	XPOXPO	$185.35	-13.68%	Brandon OglenskiBarclays 64%	145 160	Previous Overweight Current Overweight	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-14.22%	Ariel RosaCitigroup 77%	155 159	Previous Buy Current Buy	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-10.44%	Brian OssenbeckJP Morgan 69%	144 166	Previous Overweight Current Overweight	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-23.93%	Jason SeidlTD Cowen 56%	131 141	Previous Buy Current Buy	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-19.61%	J. Bruce ChanStifel 61%	140 149	Previous Buy Current Buy	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-19.07%	Christopher KuhnBenchmark 64%	140 150	Previous Buy Current Buy	Get Alert
Oct 31, 2025	XPOXPO	$185.35	-18.53%	Jonathan ChappellEvercore ISI Group 72%	141 151	Previous Outperform Current Outperform	Get Alert
Oct 28, 2025	XPOXPO	$185.35	-24.47%	J. Bruce ChanStifel 61%	136 140	Previous Buy Current Buy	Get Alert
Oct 14, 2025	XPOXPO	$185.35	-19.07%	Patrick Tyler BrownRaymond James 77%	132 150	Previous Outperform Current Outperform	Get Alert
Oct 13, 2025	XPOXPO	$185.35	-16.37%	Ariel RosaCitigroup 77%	152 155	Previous Buy Current Buy	Get Alert
Oct 8, 2025	XPOXPO	$185.35	-22.31%	Brian OssenbeckJP Morgan 69%	144 156	Previous Overweight Current Overweight	Get Alert
Oct 6, 2025	XPOXPO	$185.35	-55.22%	Ravi ShankerMorgan Stanley 58%	83 84	Previous Underweight Current Underweight	Get Alert
Oct 3, 2025	XPOXPO	$185.35	-12.6%	Thomas WadewitzUBS 75%	150 162	Previous Buy Current Buy	Get Alert
Oct 1, 2025	XPOXPO	$185.35	-24.47%	Christopher KuhnBenchmark 64%	140 140	Previous Buy Current Buy	Get Alert
Sep 30, 2025	XPOXPO	$185.35	-23.93%	Jonathan ChappellEvercore ISI Group 72%	134 141	Previous Outperform Current Outperform	Get Alert
Aug 1, 2025	XPOXPO	$185.35	-26.63%	J. Bruce ChanStifel 61%	136 145	Previous Buy Current Buy	Get Alert
Aug 1, 2025	XPOXPO	$185.35	-24.47%	Ariel RosaCitigroup 77%	140 140	Previous Neutral Current Buy	Get Alert
Aug 1, 2025	XPOXPO	$185.35	-20.69%	Christian WetherbeeWells Fargo 71%	144 147	Previous Overweight Current Overweight	Get Alert
Aug 1, 2025	XPOXPO	$185.35	-54.68%	Ravi ShankerMorgan Stanley 58%	84 85	Previous Underweight Current Underweight	Get Alert
Jul 24, 2025	XPOXPO	$185.35	-21.77%	J. Bruce ChanStifel 61%	135 145	Previous Buy Current Buy	Get Alert
Jul 15, 2025	XPOXPO	$185.35	-24.47%	Christopher KuhnBenchmark 64%	130 140	Previous Buy Current Buy	Get Alert
Jul 10, 2025	XPOXPO	$185.35	-21.77%	Brandon OglenskiBarclays 64%	135 145	Previous Overweight Current Overweight	Get Alert
Jul 9, 2025	XPOXPO	$185.35	-24.47%	Ariel RosaCitigroup 77%	137 140	Previous Buy Current Neutral	Get Alert
Jul 8, 2025	XPOXPO	$185.35	-29.86%	Brian OssenbeckJP Morgan 69%	121 130	Previous Overweight Current Overweight	Get Alert
Jul 8, 2025	XPOXPO	$185.35	-19.07%	Thomas WadewitzUBS 75%	123 150	Previous Buy Current Buy	Get Alert
Jul 7, 2025	XPOXPO	$185.35	-22.31%	Christian WetherbeeWells Fargo 71%	116 144	Previous Overweight Current Overweight	Get Alert
Jul 7, 2025	XPOXPO	$185.35	-19.07%	Scott SchneebergerOppenheimer 60%	126 150	Previous Outperform Current Outperform	Get Alert
Jul 7, 2025	XPOXPO	$185.35	-19.07%	Ken HoexterB of A Securities 66%	139 150	Previous Buy Current Buy	Get Alert
Jun 30, 2025	XPOXPO	$185.35	-27.16%	Lucas ServeraTruist Securities 72%	125 135	Previous Buy Current Buy	Get Alert
Jun 18, 2025	XPOXPO	$185.35	-21.77%	Bascome MajorsSusquehanna 63%	138 145	Previous Positive Current Positive	Get Alert
Jun 11, 2025	XPOXPO	$185.35	-24.47%	Stephanie MooreJefferies 70%	135 140	Previous Buy Current Buy	Get Alert
Jun 9, 2025	XPOXPO	$185.35	-27.16%	Brandon OglenskiBarclays 64%	125 135	Previous Overweight Current Overweight	Get Alert
Jun 5, 2025	XPOXPO	$185.35	-29.32%	Daniel ImbroStephens & Co. 77%	131 131	Previous Overweight Current Overweight	Get Alert
May 16, 2025	XPOXPO	$185.35	-25.01%	Ken HoexterB of A Securities 66%	119 139	Previous Buy Current Buy	Get Alert
May 1, 2025	XPOXPO	$185.35	-35.8%	Ken HoexterB of A Securities 66%	119 131	Previous Buy Current Buy	Get Alert
May 1, 2025	XPOXPO	$185.35	-29.32%	Daniel ImbroStephens & Co. 77%	131 131	Previous Overweight Current Overweight	Get Alert
May 1, 2025	XPOXPO	$185.35	-34.72%	Brian OssenbeckJP Morgan 69%	121 132	Previous Overweight Current Overweight	Get Alert
May 1, 2025	XPOXPO	$185.35	-37.42%	Christian WetherbeeWells Fargo 71%	116 130	Previous Overweight Current Overweight	Get Alert
May 1, 2025	XPOXPO	$185.35	-32.02%	Scott SchneebergerOppenheimer 60%	126 142	Previous Outperform Current Outperform	Get Alert

Recent Analyst Stock Rating News

PRO

Canaccord Genuity Maintains Buy on Etoro Group, Lowers Price Target to $47

Canaccord Genuity analyst Joseph Vafi maintains Etoro Group (NASDAQ:ETOR) with a Buy and lowers the price target from $53 to $47.

PRO

Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5

Jones Trading analyst Jason Weaver maintains Dynex Cap (NYSE:DX) with a Buy and lowers the price target from $14.75 to $12.5.

PRO

Scotiabank Maintains Sector Outperform on Whitecap Res, Raises Price Target to C$22

Scotiabank analyst Kevin Fisk maintains Whitecap Res (TSX:WCP) with a Sector Outperform and raises the price target from C$19 to C$22.

PRO

Scotiabank Maintains Sector Perform on Vermilion Energy, Raises Price Target to C$20

Scotiabank analyst Kevin Fisk maintains Vermilion Energy (TSX:VET) with a Sector Perform and raises the price target from C$17 to C$20.

PRO

Scotiabank Maintains Sector Perform on Trisura Group, Lowers Price Target to C$52

Scotiabank analyst Phil Hardie maintains Trisura Group (TSX:TSU) with a Sector Perform and lowers the price target from C$53 to C$52.

PRO

Scotiabank Maintains Sector Outperform on Tourmaline Oil, Lowers Price Target to C$73

Scotiabank analyst Chris MacCulloch maintains Tourmaline Oil (TSX:TOU) with a Sector Outperform and lowers the price target from C$76 to C$73.

PRO

Scotiabank Maintains Sector Outperform on Suncor Energy, Raises Price Target to C$123

Scotiabank analyst Kevin Fisk maintains Suncor Energy (TSX:SU) with a Sector Outperform and raises the price target from C$106 to C$123.

PRO

Scotiabank Maintains Sector Outperform on Spartan Delta, Raises Price Target to C$17.5

Scotiabank analyst Kevin Fisk maintains Spartan Delta (TSX:SDE) with a Sector Outperform and raises the price target from C$15.5 to C$17.5.

PRO

Scotiabank Maintains Sector Perform on PrairieSky Royalty, Raises Price Target to C$36

Scotiabank analyst Kevin Fisk maintains PrairieSky Royalty (TSX:PSK) with a Sector Perform and raises the price target from C$35 to C$36.

PRO

Scotiabank Maintains Sector Perform on Peyto Exploration & Dev, Lowers Price Target to C$27

Scotiabank analyst Chris MacCulloch maintains Peyto Exploration & Dev (TSX:PEY) with a Sector Perform and lowers the price target from C$28.5 to C$27.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website